Last reviewed · How we verify
Sham Local
Sham Local is a placebo control intervention used in clinical research to establish baseline effects in local treatment studies.
Sham Local is a placebo control intervention used in clinical research to establish baseline effects in local treatment studies. Used for Clinical trial control arm (non-therapeutic).
At a glance
| Generic name | Sham Local |
|---|---|
| Sponsor | The University of Texas Health Science Center, Houston |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
Sham Local represents a non-active local procedure or treatment administered in a manner identical to the active intervention, allowing researchers to isolate the true therapeutic effect from placebo response and procedural effects. It is used as a control arm in clinical trials to determine whether observed benefits are due to the specific mechanism of the active treatment or to non-specific factors such as patient expectation, attention, or the procedural context itself.
Approved indications
- Clinical trial control arm (non-therapeutic)
Common side effects
Key clinical trials
- The Effects of 5G Radiation on Skin (NA)
- Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty (NA)
- Efficacy Evaluation of Electroacupuncture in the Treatment of Functional Dyspepsia (NA)
- Dry Needling for Temporomandibular Disorder (NA)
- Femoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension (PHASE4)
- Modulating Oscillations and Working Memory in Patients With Subdural Electrodes (NA)
- Feasibility of an Analgesic Device Enabling Local Anesthetic Delivery and Neuromodulation After Knee Surgery (NA)
- A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |